Standout Papers
Citation Impact
Citing Papers
Sleep-Disordered Breathing, Behavior, and Cognition in Children Before and After Adenotonsillectomy
2006
Effect of rosiglitazone on spontaneous and clomiphene citrate–induced ovulation in women with polycystic ovary syndrome
2003
Intravital microscopy reveals novel antivascular and antitumor effects of endostatin delivered locally by alginate-encapsulated cells.
2001
Ex Vivo Expansion of CD4+CD25+FoxP3+ T Regulatory Cells Based on Synergy between IL-2 and 4-1BB Signaling
2007
A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2007 StandoutNobel
The Scoring of Respiratory Events in Sleep: Reliability and Validity
2007
Androgen levels during sequential insulin euglycemic clamp studies in patients with polycystic ovary disease
1988
Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus
1995
Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome
1992
A Direct Effect of Hyperinsulinemia on Serum Sex Hormone-Binding Globulin Levels in Obese Women with the Polycystic Ovary Syndrome*
1991
Thiazolidinediones
2004 Standout
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice
2008
A Multifactorial Intervention to Reduce the Risk of Falling among Elderly People Living in the Community
1994 Standout
A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: A pilot study
2004
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
THE INDEPENDENT EFFECTS OF HYPERANDROGENAEMIA, HYPERINSULINAEMIA, AND OBESITY ON LIPID AND LIPOPROTEIN PROFILES IN WOMEN*
1990
Mortality of Women with Polycystic Ovary Syndrome at Long-term Follow-up
1998
Polysomnographic values in children 2–9 years old: Additional data and review of the literature
2005
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
Clinical Course of Genetic Diseases of the Insulin Receptor (Type A and Rabson-Mendenhall Syndromes)
2004
Polymorphism of the follistatin gene in polycystic ovary syndrome
2007
Follicle dynamics and anovulation in polycystic ovary syndrome
2008
Therapeutic activity of 3,3′‐diindolylmethane on prostate cancer in an in vivo model
2004
Diabetes Prevalence and Risk Factors in Polycystic Ovary Syndrome
2001
Pancreatic cancer
2020 Standout
Impaired Adipocyte Lipolysis in Nonobese Women with the Polycystic Ovary Syndrome: A Possible Link to Insulin Resistance?1
1997
Hydrogels for tissue engineering: scaffold design variables and applications
2003 Standout
Acanthosis Nigricans, Insulin Action, and Hyperandrogenism: Clinical, Histological, and Biochemical Findings*
1991
A Fasting Glucose to Insulin Ratio Is a Useful Measure of Insulin Sensitivity in Women with Polycystic Ovary Syndrome1
1998
Schizophrenia
2009 Standout
Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome
2000
Erectile Dysfunction
2000 Standout
Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study
2005 Standout
Snoring and Obstructive Sleep Apnea in Children
2000
Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome
2002
DIET‐INDUCED CHANGES IN SEX HORMONE BINDING GLOBULIN AND FREE TESTOSTERONE IN WOMEN WITH NORMAL OR POLYCYSTIC OVARIES: CORRELATION WITH SERUM INSULIN AND INSULIN‐LIKE GROWTH FACTOR‐I
1989
Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.
1995
Pretreatment CA 19-9 Level as a Prognostic Factor in Patients with Advanced Pancreatic Cancer Treated with Gemcitabine
2002
Obesity-Related Lipid Profile and Altered Insulin Incretion in Adolescents With Polycystic Ovary Syndrome
2010
DIFFERENCES IN CLINICAL AND ENDOCRINE FEATURES BETWEEN OBESE AND NON‐OBESE SUBJECTS WITH POLYCYSTIC OVARY SYNDROME: AN ANALYSIS OF 263 CONSECUTIVE CASES
1990
Vitamin D Deficiency
2007 Standout
Pancreatic cancer
2016 Standout
Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010
2011
Metformin for the Treatment of the Polycystic Ovary Syndrome
2008
Formation and early development of follicles in the polycystic ovary
2003
Heat Stroke
2002 Standout
Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome
2004
Effects of Metformin on Insulin Secretion, Insulin Action, and Ovarian Steroidogenesis in Women with Polycystic Ovary Syndrome1
1997
Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome
1998
Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome.
1989
Inhibition of Sex Hormone-Binding Globulin Production in the Human Hepatoma (Hep G2) Cell Line by Insulin and Prolactin*
1988
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Sleep Disordered Breathing: Surgical Outcomes in Prepubertal Children
2003
A Modern Medical Quandary: Polycystic Ovary Syndrome, Insulin Resistance, and Oral Contraceptive Pills
2003
Angiogenesis in health and disease
2003 Standout
Clinical signs of androgen excess as risk factors for coronary artery disease
1990
Polycystic Ovaries Are Common in Women with Hyperandrogenic Chronic Anovulation but Do Not Predict Metabolic or Reproductive Phenotype
2005
Dyslipidemia and Metabolic Syndrome in the Sisters of Women with Polycystic Ovary Syndrome
2005
Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables
1994
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Absence of insulin receptor gene mutations in three insulin-resistant women with the polycystic ovary syndrome
1994
Lack of linear relationship between hyperinsulinaemia and hyperandrogenism
1992
Participation in Cancer Clinical Trials
2004 Standout
Localization of Collagen XVIII and the Endostatin Portion of Collagen XVIII in Aged Human Control Eyes and Eyes with Age-Related Macular Degeneration
2004
Suppression of Serum Insulin by Diazoxide Reduces Serum Testosterone Levels in Obese Women with Polycystic Ovary Syndrome*
1989
Menstrual Cycle Irregularity and Risk for Future Cardiovascular Disease
2002
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
2006 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy
1994
Selective Insulin Resistance in the Polycystic Ovary Syndrome1
1999
Metabolic and endocrine effects of treatment with peroral or transdermal oestrogens in conjunction with peroral cyproterone acetate in women with polycystic ovary syndrome
2004
Polycystic Ovary Syndrome
1995 Standout
Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?
2005
Angiogenesis in life, disease and medicine
2005 StandoutNature
Polycystic ovary syndrome and risk for myocardial infarction: Evaluated from a risk factor model based on a prospective population study of women
1992
Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome
2007
Troglitazone Improves Defects in Insulin Action, Insulin Secretion, Ovarian Steroidogenesis, and Fibrinolysis in Women with Polycystic Ovary Syndrome1
1997
Obesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinaemia, dyslipidaemia and hypertension in ageing women with polycystic ovary syndrome
2001
POLYCYSTIC OVARY SYNDROME: A CHANGING PERSPECTIVE
1989
Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome?
2001
Autoantibody response to heat shock protein 70 in patients with heatstroke
2001
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Obesity, lipids, cardiovascular risk, and androgen excess
1995
Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering
2005 Standout
The genetic basis of polycystic ovary syndrome
1997
Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?
2002
Nutrition, hormones, and breast cancer: Is insulin the missing link?
1996
Combination CTLA-4 Blockade and 4-1BB Activation Enhances Tumor Rejection by Increasing T-Cell Infiltration, Proliferation, and Cytokine Production
2011 StandoutNobel
Polycystic Ovary Syndrome
2005 Standout
THE EPIDEMIOLOGY OF POLYCYSTIC OVARY SYNDROME
1999
Molecular regulation of vessel maturation
2003 Standout
Pharmacotherapy of schizophrenia with comorbid substance use disorder — Reviewing the evidence and clinical recommendations
2008
Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome
1994
Correlation of plasma insulin and insulin‐like growth factor‐I with indices of androgen transport and metabolism in women with polycystic ovary syndrome
1991
Reversal of Relation Between Body Mass and Endogenous Estrogen Concentrations With Menopausal Status
1996
HIV as the cause of AIDS
1996 StandoutNobel
EFFECTS OF LUTEINIZING HORMONE, INSULIN, INSULIN‐LIKE GROWTH FACTOR‐I AND INSULINLIKE GROWTH FACTOR SMALL BINDING PROTEIN 1 IN THE POLYCYSTIC OVARY SYNDROME
1990
Obesity and Polycystic Ovary Syndromea
1991
Altered Vascular Function in Young Women with Polycystic Ovary Syndrome
2002
Suppression of serum insulin level by diazoxide does not alter serum testosterone or sex hormone-binding globulin levels in healthy, nonobese women
1990
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
The Effects of Oral Dehydroepiandrosterone on Endocrine-Metabolic Parameters in Postmenopausal Women*
1990
Changes in Sexual Function in Middle‐Aged and Older Men: Longitudinal Data from the Massachusetts Male Aging Study
2004
Technical Report: Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome
2002
β-Cell Function: A Key Pathological Determinant in Polycystic Ovary Syndrome
2005
Suppression of Hyperandrogenism Does not Improve Peripheral or Hepatic Insulin Resistance in the Polycystic Ovary Syndrome*
1990
Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.
1995
Fecundability and spontaneous abortions in women with self-reported oligo-amenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study
2008
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
2003 Standout
Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome
2000
Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity?
2004
Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets?
2003
The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long‐term oestrogen–progestagen treatment
1999
Insulin Resistance in the Sisters of Women with Polycystic Ovary Syndrome: Association with Hyperandrogenemia Rather Than Menstrual Irregularity
2002
Polycystic ovary syndrome
1997
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Acute insulin response to intravenous glucagon in polycystic ovary syndrome
1998
Current strategies in the management of hormone refractory prostate cancer
2003
Premature Response to Luteinizing Hormone of Granulosa Cells from Anovulatory Women with Polycystic Ovary Syndrome: Relevance to Mechanism of Anovulation1
1998
INSULIN ACTION IN THE NORMAL AND POLYCYSTIC OVARY
1999
Hyperinsulinemia in the polycystic ovary syndrome: a clinical, endocrine and echographic study in 240 patients
1996
Reproductive endocrinologic alterations in female asymptomatic obesity
1989
A Study of Sexuality and Health among Older Adults in the United States
2007 Standout
Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia
2004
Understanding and altering cell tropism of vesicular stomatitis virus
2013
Hyperinsulinaemia in the polycystic ovary syndrome confirmed with a specific immunoradiometric assay for insulin
1993
Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance
1992
Long or Highly Irregular Menstrual Cycles as a Marker for Risk of Type 2 Diabetes Mellitus
2001
Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia
1999
Depressive Signs and Symptoms in Schizophrenia
1998
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women1
1999 Standout
Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome.
1996
The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women
1994
Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin
1992
The Effects of Experimental Hyperinsulinemia on Steroid Secretion, Ovarian [125I]Insulin Binding, and Ovarian [125I]Insulin-Like Growth-Factor I Binding in the Rat*
1988
Endostatin Gene Transfer Inhibits Joint Angiogenesis and Pannus Formation in Inflammatory Arthritis
2002
Orthostatic Hypotension in the Elderly
1989
Birth weight in offspring of mothers with polycystic ovarian syndrome
2005
Manipulating angiogenesis in medicine
2004
Practice Parameters for the Respiratory Indications for Polysomnography in Children
2011
Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer
2001
The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.
1996
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
Bis- and Trisindolylmethanes (BIMs and TIMs)
2009 Standout
Sex steroids and insulin resistance
2002
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Ultraviolet B–Induced Maturation of CD11b-Type Langerin− Dendritic Cells Controls the Expansion of Foxp3+ Regulatory T Cells in the Skin
2017 StandoutNobel
Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.
2002
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001 Standout
Intrauterine Growth Retardation Predisposes to Insulin Resistance But Not to Hyperandrogenism in Young Women
1999
Risk of T2DM and impaired fasting glucose among pcos subjects: Results of an 8-year follow-up
2006
The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women.
1996
Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome
2012 Standout
Determinants of Abnormal Gonadotropin Secretion in Clinically Defined Women with Polycystic Ovary Syndrome1
1997
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism.
1996
Polycystic Ovary Syndrome and Cardiovascular Disease: A Premature Association?
2003
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
1997 Standout
Acanthosis nigricans: Clinical predictor of abnormal glucose tolerance in Asian women with polycystic ovary syndrome
2005
Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting
2010
From Density to Structure: Growing Up and Growing Old on the Surfaces of Bone
1997
Heritability of Insulin Secretion and Insulin Action in Women with Polycystic Ovary Syndrome and Their First Degree Relatives1
2001
The effects of knowledge, attitudes, and significant others on decisions to enroll in a clinical trial on osteoporosis: implications for recruitment of older African-American women.
2001
Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes
1993
Pathogenesis of human immunodeficiency virus infection
1993
Premature Adrenarche—Normal Variant or Forerunner of Adult Disease?*
2000
Decreased insulin sensitivity in prepubertal girls with premature adrenarche and acanthosis nigricans.
1995
Differential effects of oral glucose-mediated versus intravenous hyperinsulinemia on circulating androgen levels in women
1993
Effect of a High-Flow Open Nasal Cannula System on Obstructive Sleep Apnea in Children
2009
The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing
2000
Immunogene Therapy of Tumors with Vaccine Based on Xenogeneic Epidermal Growth Factor Receptor
2003
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Genetic Basis of Metabolic Abnormalities in Polycystic Ovary Syndrome
2004
Subjective sleepiness and polysomnographic correlates in children scheduled for adenotonsillectomy vs other surgical care.
2006
Genetic analysis of candidate genes for the polycystic ovary syndrome
2002
Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency.
1992
Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance.
1994
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
2000 Standout
Insulin as an Effector of Human Ovarian and Adrenal Steroid Metabolism
1991
Therapeutic cancer vaccines
2015
Metabolic effects of oral contraceptives in women with polycystic ovary syndrome.
1995
Development of a Health-Related Quality-of-Life Questionnaire (PCOSQ) for Women with Polycystic Ovary Syndrome (PCOS)1
1998
Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome
2006
Changes in Glucose Tolerance over Time in Women with Polycystic Ovary Syndrome: A Controlled Study
2005
Effect of ethnicity and age or menopause on the structure and geometry of iliac bone
1996
Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion
2016 StandoutNobel
Regulation of Wound Healing by Growth Factors and Cytokines
2003 Standout
Role of Brain Insulin Receptor in Control of Body Weight and Reproduction
2000 StandoutScience
Can metformin reduce insulin resistance in polycystic ovary syndrome?
1996
Works of John Mandeli being referenced
Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
2019
Effect of Testosterone Administration on Sexual Behavior and Mood in Men with Erectile Dysfunction
1997
T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer
2002
Histories of substance abuse in patients with postpsychotic depressions
1988
Radial and Vertebral Bone Density in White and Black Women: Evidence for Racial Differences in Premenopausal Bone Homeostasis*
1989
Assessment of inspiratory flow limitation in children with sleep‐disordered breathing by a nasal cannula pressure transducer system
2002
Tumor markers in patients with pancreatic carcinoma
1996
The Impact of Obesity and Chronic Hyperinsulinemia on Gonadotropin Release and Gonadal Steroid Secretion in the Polycystic Ovary Syndrome*
1988
rVSV(MΔ51)-M3 Is an Effective and Safe Oncolytic Virus for Cancer Therapy
2008
Postpsychotic depression and negative symptoms: an investigation of syndromal overlap
1988
Characterization of Groups of Hyperaiidrogenic Women with Acanthosis Nigricans, Impaired Glucose Tolerance, and/or Hyperinsulinemia*
1987 Standout
A Phase I/II study of weekly paclitaxel and 3 days of high dose oral estramustine in patients with hormone-refractory prostate carcinoma
2001
Evaluation of home audiotapes as an abbreviated test for obstructive sleep apnea syndrome (OSAS) in children
1999
Healthy aging and male sexual function
1990
Fluphenazine decanoate dose and severity of depression in patients with post-psychotic depression
1988
Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha‐adrenergic agonist (midodrine)
1988
Specific antibody responses to synthetic peptides of HIV-1 p17 correlate with different stages of HIV-1 infection.
1992
Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases
2000